Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03318380 · ClinicalTrials.gov registry record · NA
Contrast-Enhanced Ultrasound Imaging in Diagnosing Liver Cancer in Patients With Cirrhosis
A NA study, sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.
- Completed
- Registry status
- NA
- Development phase
- 612
- Enrollment target
NCT03318380 is a NA study that has completed, run by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University. The registered enrollment target is 612 participants.
The verdict
NCT03318380, a NA study, has completed, sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University.
- COMPLETED
- Registry status
- NA
- Development phase
- 612 participants
- Enrollment target
Study Summary
This clinical trial studies how well contrast-enhanced ultrasound imaging works in diagnosing liver cancer in patients with cirrhosis. Diagnostic procedures, such as contrast-enhanced ultrasound imaging, may help find and diagnose liver cancer.
Interventions
- PROCEDURE Dynamic Contrast-Enhanced Ultrasound Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 612 participants |
| Start Date | 2018-01-19 |
| Est. Completion | 2022-11-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03318380
The ClinicalTrials.gov registry entry for NCT03318380 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 612 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, which has 138 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dynamic Contrast-Enhanced Ultrasound Imaging is the first listed.
NCT03318380 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03318380 about?
NCT03318380 is a clinical study titled "Contrast-Enhanced Ultrasound Imaging in Diagnosing Liver Cancer in Patients With Cirrhosis". This clinical trial studies how well contrast-enhanced ultrasound imaging works in diagnosing liver cancer in patients with cirrhosis. Diagnostic procedures, such as contrast-enhanced ultrasound imaging, may help find and diagnose liver cancer.
What is the current status of trial NCT03318380?
This trial is currently completed. It is a NA study. The enrollment target is 612 participants. The study started on 2018-01-19. Estimated completion is 2022-11-03.
What interventions are being tested in trial NCT03318380?
The interventions under investigation include: Dynamic Contrast-Enhanced Ultrasound Imaging (PROCEDURE).
Who is sponsoring clinical trial NCT03318380?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, which has 138 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.